Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing in dermatology, primarily commercializing photodynamic therapy (PDT) products for treating actinic keratosis. Its core offerings include the prescription drug Ameluz® and RhodoLED® lamps, used together for targeted skin lesion treatment. Biofrontera markets these products directly to dermatology providers in the U.S., leveraging exclusive licensing agreements and focusing on clinical development, regulatory compliance, and reimbursement to support adoption.
This description was generated via AI from an annual report. Updated about 1 year ago.